SCHEMBL4640933

SCHEMBL4640933

CCCC(CC)OC(=O)c1cc(C)c(CC)cc1C(=O)OC(CC)CCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.51
PRKCD Q05655 2/20 0.51
PPARG P37231 3/20 0.33
PPARD Q03181 3/20 0.33
ALDH1A1 P00352 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
UTS2R Q9UKP6 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
SHBG P04278 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PPARA Q07869 2/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
GRM1 Q13255 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640934 0.94 PRKCA (0.47) PRKCAPRKCDPPARGPPARDALDH1A1
SCHEMBL4643120 0.94 PRKCA (0.47) PRKCAPRKCDPPARGPPARDALDH1A1
SCHEMBL4640589 0.91 PRKCA (0.56) PRKCAPRKCDPPARGALDH1A1L3MBTL1
SCHEMBL4644160 0.91 PRKCA (0.56) PRKCAPRKCDPPARGALDH1A1L3MBTL1
SCHEMBL4640632 0.88 PRKCA (0.40) PRKCAPRKCDPPARGPPARDL3MBTL1
SCHEMBL4640593 0.85 PRKCA (0.51) PRKCAPRKCDPPARGALDH1A1TSHR
SCHEMBL4644162 0.85 PRKCA (0.51) PRKCAPRKCDPPARGALDH1A1L3MBTL1
SCHEMBL4640664 0.84 PRKCA (0.36) PRKCAPRKCDPPARGPPARDALDH1A1
SCHEMBL4640634 0.84 PRKCA (0.36) PRKCAPRKCDPPARGPPARDALDH1A1
SCHEMBL4627358 0.84 PRKCA (0.50) PRKCAPRKCDALDH1A1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX PRKCA 1200/4885PRKCD 552/4885PPARG 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.